| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |